Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Merz says army could be involved in mine-clearing from Hormuz - 2How did I get my own unique set of fingerprints?
- 3Australian State Triggers Emergency Powers Amid Fuel Crisis
- 4Astronomers may have spotted the 1st known 'superkilonova' double star explosion
- 5Understanding Various Sorts of Financial balances: An Extensive Outline
- Shadow Cats: The Elusive Leopards Surviving Against Impossible Odds
- What to watch for as NASA’s historic Artemis II crew prepares to lift off toward the moon
- Guinea-Bissau's coup called a 'sham' by West African political figures
- Genome study reveals milestone in history of cat domestication
- Volkswagen in talks with defence firms on use of Germany plant: CEO
- Research highlights potential dangers of ultra-processed foods for women under 50 regarding precancerous polyps
- 5 Great Youngster Care Administrations To Watch in 2024
- From Educational Loans to Obligation Free: Independence from the rat race Accomplished
- Want to make America healthy again? Stop fueling climate change
